Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Recurrent or Progressive Malignant Gliomas
NCT00337207Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Mar 2006
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in malignant glioma, sponsored by Northwestern University. Started Mar 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00337207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337207.